FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
UNITY VCS (8065000296); UNITY CS (8065000297)
K Number: K233876
·
Decision Jun 21, 2024
Classifications
1
FEI Numbers
71
Registration Numbers
71
Same Product Code
311
Applicant Total
3
Review Days
197
Basic Information
- Device Name
- UNITY VCS (8065000296); UNITY CS (8065000297)
- K Number
- K233876
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 886.4670
- Medical Specialty
- Ophthalmic
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Alcon Laboratories Inc.
- Date Received
- December 7, 2023
- Decision Date
- June 21, 2024
- Product Code
- HQC
- Advisory Committee
- Ophthalmic
- Review Advisory Committee
- OP
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| HQC | Unit, Phacofragmentation | FDA class 2 | Ophthalmic |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (HQC), ordered by most recent decision date.
MICOR 700 System (N/A); MICOR 700 drive (FG-50631); MICOR 700 extractor (FG-50621); MICOR 700 vitrector (FG-51185)
FDA 510(k)
FDA Class 2
·Ophthalmic
Stellaris Elite vision enhancement system (BL11145, BL14455, BL15455)
FDA 510(k)
FDA Class 2
·Ophthalmic
Faros Surgical System
FDA 510(k)
FDA Class 2
·Ophthalmic
Stellaris Elite vision enhancement system
FDA 510(k)
FDA Class 2
·Ophthalmic
Centurion Vision System (Active Sentry) (8065753057)
FDA 510(k)
FDA Class 2
·Ophthalmic
QUATERA 700
FDA 510(k)
FDA Class 2
·Ophthalmic
Other Clearances by Alcon Laboratories Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K242184 | Alcon 27GA Chandelier (8065000252); Alcon 27+ DS Wide Angle Endoilluminator (8065000253); Alcon 27+ DS Endoilluminator (8065000256); | Dec 4, 2024 | Substantially Equivalent |
| K210436 | Total30, Total30 for Astigmatism, Total30 Multifocal, Total30 Multifocal Toric, Total30 Asphere | Apr 12, 2021 | Substantially Equivalent |